A 20-week, Multi-centre, Open-labelled, Non-comparative Evaluation of the Safety and Efficacy of Insulin Detemir in Combination With Oral Anti-diabetic Drug(s), in Subjects With Type 2 Diabetes Mellitus Who Were Inadequately Controlled on Current Therapy in Korea.
Phase of Trial: Phase IV
Latest Information Update: 26 Dec 2014
At a glance
- Drugs Insulin detemir (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 31 Aug 2018 Biomarkers information updated
- 12 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.